D-0204-2026 Class II Ongoing

Recalled by Blossom Pharmaceuticals — Bardej, Goa

FDA drug recall D-0204-2026 was initiated by Blossom Pharmaceuticals on Oct 31, 2025 and is designated Class II. Reason for recall: cGMP deviations The recall status is ongoing. Affected quantity: 8184 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 10, 2025
Initiation Date
Oct 31, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8184 bottles

Product description

Dynagel, Moisturizing Wound Hydrogel, Net Wt. 3oz (84.7 g), Manufactured for: Dynarex Corporation, 16 Glenshaw Street, Orangeburg, NY 10962, UPC 61784128016.

Reason for recall

cGMP deviations

Distribution pattern

USA Nationwide

Code information

Lot #: A322301, Exp. Date 7/26 & A322302, Exp. Date 8/26

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0204-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0204-2026. Report a data issue: hello@regdatalab.com.